Unlocking renal Restoration: Mesaconine from Aconitum plants restore mitochondrial function to halt cell apoptosis in acute kidney injury
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mesaconine, derived from Fuzi, shows promise in treating acute kidney injury (AKI) by protecting kidney cells, reducing inflammation, and preventing apoptosis. This low-toxicity compound offers a potential new therapeutic avenue for AKI management.
Area Of Science
- Nephrology
- Pharmacology
- Traditional Chinese Medicine
Background
- Acute kidney injury (AKI) is a critical condition with limited treatment options.
- Traditional Chinese medicine's Fuzi has shown efficacy but carries toxicity concerns.
- Mesaconine, a processed Fuzi derivative, presents a potential low-toxicity alternative for AKI.
Purpose Of The Study
- To evaluate the protective effects of mesaconine against gentamicin-induced acute kidney injury (AKI) in vitro and in vivo.
- To investigate the underlying mechanisms of mesaconine's renoprotective actions.
Main Methods
- In vitro: NRK-52E cells were treated with gentamicin and mesaconine.
- In vivo: Gentamicin-induced AKI rat models were treated with mesaconine.
- Assessed cell viability, mitochondrial function, inflammatory markers, apoptosis, and renal histopathology.
Main Results
- Mesaconine promoted NRK-52E cell proliferation and reduced TGF-β1 and KIM-1.
- It restored mitochondrial function, decreased inflammation, and inhibited apoptosis in vitro.
- In vivo, mesaconine improved renal function biomarkers, reduced oxidative stress, and mitigated kidney damage and inflammation.
- Mesaconine modulated apoptotic protein expression, promoting survival signals.
Conclusions
- Mesaconine demonstrates significant therapeutic potential for acute kidney injury.
- Its renoprotective effects are attributed to mitochondrial restoration, anti-inflammatory, antioxidant, and anti-apoptotic properties.
- Mesaconine is a promising candidate for further clinical investigation in AKI management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...